skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. CLS: Two questions. [Celestica Inc.]
You can view 1 more answer this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Two questions. You mentioned earlier today selling VRT and adding to NBIS to consolidate positions. Do you feel the growth is better in NBIS and outweighs the benefit of diversification? Overall direct AI exposure. I have VRT (3%) NBiS (2%) CLS (2.5%) NVDA (4%). Would you personally feel ok with this much direct exposure for the next 12-16 months? Increase or decrease? I didn’t included my 6% position in Google but maybe should have?
Asked by Don on October 21, 2025
5i Research Answer:

Personally we would be fine with the noted weighting for the noted timeframe. AI spending is actually accelerating right now. This won't last, but takes the short term pressure off. We would be fine owning VRT and NBIS but the prior question was looking to consolidate. GOOG has some AI exposure of course but we would treat it somewhat differently than these others. 

Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in NVDA, NBIS.